PRMT1 promotes neuroblastoma cell survival through ATF5

Aberrant expression of protein arginine methyltransferases (PRMTs) has been implicated in a number of cancers, making PRMTs potential therapeutic targets. But it remains not well understood how PRMTs impact specific oncogenic pathways. We previously identified PRMTs as important regulators of cell g...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Zhong-Yan, Hansen, Jeanne N., He, Miao, Dai, Shang-Kun, Choi, Yoonjung, Fulton, Melody D., Lloyd, Sarah M., Szemes, Marianna, Sen, Ji, Ding, Han-Fei, Angelastro, James M., Fei, Xiang, Li, Hui-Ping, Wu, Chao-Ran, Yang, Sheng-Yong, Malik, Karim, Bao, Xiaomin, George Zheng, Y., Liu, Chang-Mei, Schor, Nina F., Li, Zhi-Jie, Li, Xing-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229216/
https://www.ncbi.nlm.nih.gov/pubmed/32415090
http://dx.doi.org/10.1038/s41389-020-0237-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229216/
https://www.ncbi.nlm.nih.gov/pubmed/32415090
http://dx.doi.org/10.1038/s41389-020-0237-9

Ejemplares similares